Early vs Late Dinner for Obesity
(DTOP Trial)
Trial Summary
What is the purpose of this trial?
Obesity and its metabolic complications are leading causes of global morbidity and mortality. Evidence is mounting that inappropriate timing of food intake contributes to obesity. Specifically, late eating is associated with greater weight gain and metabolic syndrome. However, the mechanism by which late eating harms metabolism is not fully understood but may be related to mis-timing of food intake in relation to the body's endogenous circadian rhythm. Conversely, harmonization of eating timing with endogenous circadian rhythm may optimize metabolic health. In this study the investigators will use gold-standard methods of characterizing circadian rhythm in humans to examine the metabolic impacts food timing relative to endogenous circadian rhythm.
Will I have to stop taking my current medications?
Yes, you may need to stop taking certain medications. The trial excludes participants taking prescription medications or drugs that may influence metabolism, such as diet/weight-loss medication, asthma medication, blood pressure medication, psychiatric medications, and others. It's best to discuss your specific medications with the study team.
What data supports the effectiveness of the treatment Early vs Late Dinner for Obesity?
Research shows that time-restricted eating (TRE), which involves eating earlier in the day, can improve blood sugar control and reduce body weight and waist circumference in people with overweight and obesity. Additionally, eating late can increase hunger and decrease energy use, which may contribute to weight gain.12345
Is time-restricted eating safe for humans?
How does the treatment of early vs late dinner for obesity differ from other treatments?
This treatment focuses on the timing of meals, specifically eating dinner early or late, which is unique compared to other obesity treatments that may focus on calorie restriction or specific diets. It leverages the body's natural circadian rhythms (internal body clock) to potentially improve metabolism and reduce hunger, which is different from traditional methods that do not consider meal timing.39101112
Research Team
Jonathan Jun, MD
Principal Investigator
Johns Hopkins University
Stephanie T Chung, MBBS
Principal Investigator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Eligibility Criteria
Adults aged 18-50 with obesity and prediabetes (BMI ≥30 kg/m2) or healthy subjects with a BMI of 18-24.9 can join this study. Participants must understand the procedures, not have metabolic disorders, gastrointestinal surgeries, severe sleep issues, or be on certain medications that affect metabolism.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Circadian Phenotyping
Participants undergo circadian phenotyping with assessment of DLMO, core body temperature profile, and wrist actigraphy
Treatment
Participants are randomized to early or late dinner conditions in a 24-hour metabolic chamber protocol, with a crossover design and a 3- to 4-week washout period
Follow-up
Participants are monitored for metabolic outcomes such as glucose and fat oxidation levels
Treatment Details
Interventions
- Early Dinner
- Early Dinner tracer
- Late Dinner
- Late Dinner tracer
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator